ALACHUA, Fla.--(BUSINESS WIRE)--RTI Biologics, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, dental, surgical specialties and other biologic implants, is launching two new biologic implants for use in sports medicine surgeries at the American Academy of Orthopaedic Surgeons (AAOS) annual meeting in Las Vegas this week. Matrix HD™, the first RTI dermis graft for sports medicine, and fresh-stored osteochondral (OC) talus allograft, an expansion of RTI’s fresh OC line, are both now available through RTI’s direct representatives and distributors.
